Psychopharmacology

• 

  Publication Venue For

  • Lack of consistent sex differences in D-amphetamine-induced dopamine release measured with [18F]fallypride PET..  236:581-590. 2019
  • Negative affect subtypes and craving differentially predict long-term cessation success among smokers achieving initial abstinence..  234:761-771. 2017
  • Abnormal fronto-limbic engagement in incarcerated stimulant users during moral processing..  233:3077-3087. 2016
  • FACS analysis of neuronal-glial interactions in the nucleus accumbens following morphine administration..  230:525-535. 2013
  • Erratum: Smoking withdrawal is associated with increases in brain activation during decision making and reward anticipation: A preliminary study.  219:685-686. 2012
  • Elevated gray and white matter densities in cocaine abstainers compared to current users.  218:681-692. 2011
  • Nicotine withdrawal modulates frontal brain function during an affective Stroop task.  1-12. 2011
  • Comparison of 50- and 100-g L -tryptophan depletion and loading formulations for altering 5-HT synthesis: pharmacokinetics, side effects, and mood states..  198:431-445. 2008
  • Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings..  197:675-681. 2008
  • Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study..  197:95-105. 2008
  • DRD4 VNTR polymorphism is associated with transient fMRI-BOLD responses to smoking cues..  194:433-441. 2007
  • A single high dose of cocaine induces differential sensitization to specific behaviors across adolescence..  193:247-260. 2007
  • Habit formation and the loss of control of an internal clock: inverse relationship between the level of baseline training and the clock-speed enhancing effects of methamphetamine..  193:351-362. 2007
  • Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats..  191:867-877. 2007
  • Guidelines on nicotine dose selection for in vivo research..  190:269-319. 2007
  • Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats..  189:435-445. 2007
  • Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial..  189:125-133. 2006
  • Ventral hippocampal alpha7 and alpha4beta2 nicotinic receptor blockade and clozapine effects on memory in female rats..  188:597-604. 2006
  • Single-trials analyses demonstrate that increases in clock speed contribute to the methamphetamine-induced horizontal shifts in peak-interval timing functions..  188:201-212. 2006
  • Neuroactive steroids, negative affect, and nicotine dependence severity in male smokers..  186:462-472. 2006
  • Subjective effects and changes in steroid hormone concentrations in humans following acute consumption of alcohol..  186:451-461. 2006
  • Nicotine and nonnicotine factors in cigarette addiction..  184:274-285. 2006
  • Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization..  184:523-539. 2006
  • Relationship of disinhibition and aggression to blunted prolactin response to meta-chlorophenylpiperazine in cocaine-dependent patients..  185:123-132. 2006
  • Timing of nicotine effects on learning in zebrafish..  184:547-552. 2006
  • Erratum: Enhanced behavioral response to related-dose cocaine in adolescent rats (Psychopharmacology (2005) 183 (218-225) DOI: doi.org/10.1007/s00213-005- 0159-4).  183:506. 2006
  • Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment..  184:21-25. 2006
  • Enhanced behavioral response to repeated-dose cocaine in adolescent rats..  183:218-225. 2005
  • Differential effects of clozapine and haloperidol on interval timing in the supraseconds range..  182:232-244. 2005
  • Characterization of conditioned place preference to cocaine in congenic dopamine transporter knockout female mice..  180:408-413. 2005
  • Nicotinic-serotonergic drug interactions and attentional performance in rats..  179:521-528. 2005
  • Assessing methylphenidate preference in ADHD patients using a choice procedure..  175:391-398. 2004
  • Relationship of serum prolactin with severity of drug use and treatment outcome in cocaine dependence..  176:74-81. 2004
  • MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout mice..  173:310-317. 2004
  • Case report: Successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine..  173:227-228. 2004
  • Effects of periadolescent versus adult cocaine exposure on cocaine conditioned place preference and motor sensitization in mice..  173:41-48. 2004
  • Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment..  171:465-471. 2004
  • Time-dependent recovery from the effects of 6-hydroxydopamine lesions of the rat nucleus accumbens on cocaine self-administration and the levels of dopamine in microdialysates..  171:413-420. 2004
  • Adolescent-onset nicotine self-administration modeled in female rats..  169:141-149. 2003
  • Source monitoring improvement in patients with schizophrenia receiving antipsychotic medications..  169:383-389. 2003
  • Differences in platelet serotonin transporter sites between African-American tobacco smokers and non-smokers..  166:221-227. 2003
  • Effects of nicotine and mecamylamine on choice accuracy in an operant visual signal detection task in female rats..  164:369-375. 2002
  • Chronic inhibition of alpha4beta2 nicotinic receptors in the ventral hippocampus of rats: impacts on memory and nicotine response..  160:140-145. 2002
  • Haloperidol reduces smoking of both nicotine-containing and denicotinized cigarettes..  159:31-37. 2001
  • St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature..  153:402-414. 2001
  • Opiate withdrawal in the neonatal rat: relationship to duration of treatment and naloxone dose..  150:253-259. 2000
  • Application of microdialysis and voltammetry to assess dopamine functions in genetically altered mice: correlation with locomotor activity..  147:30-32. 1999
  • Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease..  143:158-165. 1999
  • Naltrexone blockade of nicotine effects in cigarette smokers..  143:339-346. 1999
  • Antidepressant effects of nicotine in an animal model of depression..  142:193-199. 1999
  • The δ₂ -opioid receptor antagonist naltriben reduces motivated responding for ethanol.  147:81-89. 1999
  • Transdermal nicotine effects on attention..  140:135-141. 1998
  • Nicotinic acetylcholine involvement in cognitive function in animals..  138:217-230. 1998
  • Altered cocaine potency in the nucleus accumbens following 7-day withdrawal from intermittent but not continuous treatment: voltammetric assessment of dopamine uptake in the rat..  137:303-310. 1998
  • Blocking GABA(A) receptors in the anterior ventral tegmental area attenuates ethanol intake of the alcohol-preferring P rat.  139:108-116. 1998
  • Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat..  133:7-16. 1997
  • Psychomotor effects of the anxiolytic abecarnil: a comparison with lorazepam..  131:101-107. 1997
  • Nicotine self-administration in animals and humans: similarities and differences..  130:28-40. 1997
  • A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal.  131:123-129. 1997
  • Ontogeny of the behavioral response to dopamine agonists after chronic cocaine..  129:121-127. 1997
  • Behavioral differences between two inbred strains of Fawn-Hooded rat: a model of serotonin dysfunction..  128:328-330. 1996
  • Chronic nicotine working and reference memory effects in the 16-arm radial maze: interactions with D1 agonist and antagonist drugs..  127:25-30. 1996
  • Effects of intermittent and continuous cocaine administration on dopamine release and uptake regulation in the striatum: in vitro voltammetric assessment..  126:331-338. 1996
  • A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia.  124:168-175. 1996
  • Acute and chronic nicotine effects on working memory in aged rats..  123:88-97. 1996
  • Nicotine effects on adults with attention-deficit/hyperactivity disorder..  123:55-63. 1996
  • Ontogenetic studies of tolerance development: effects of chronic morphine on the hypothalamic-pituitary-adrenal axis..  122:78-84. 1995
  • Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression..  121:27-37. 1995
  • Haloperidol increases smoking in patients with schizophrenia..  119:124-126. 1995
  • Alcohol pharmacodynamics in young-elderly adults contrasted with young and middle-aged subjects..  118:460-470. 1995
  • Effects of ibogaine on responding maintained by food, cocaine and heroin reinforcement in rats..  117:257-261. 1995
  • The delta opioid receptor antagonist naltrindole attenuates both alcohol and saccharin intake in rats selectively bred for alcohol preference.  120:177-185. 1995
  • Comparison in humans of the potency and pharmacokinetics of intravenously injected cocaethylene and cocaine..  116:428-432. 1994
  • The benzodiazepine inverse agonist RO19-4603 exerts prolonged and selective suppression of ethanol intake in alcohol-preferring (P) rats.  115:325-331. 1994
  • Addition of lithium to haloperidol in non-affective, antipsychotic non-responsive schizophrenia: A double blind, placebo controlled, parallel design clinical trial.  111:359-366. 1993
  • An open study of the pharmacokinetics and the tolerability of raclopride extended release capsules in psychiatric patients.  112:371-374. 1993
  • Dopamine efflux during withdrawal from continuous or intermittent cocaine..  111:179-184. 1993
  • Effects of oral ethanol self-administration on the EEG of alcohol preferring and -nonpreferring rats.  113:60-66. 1993
  • Corticotropin releasing factor (CRF): studies in alcohol preferring and non-preferring rats..  106:359-364. 1992
  • Differences in the hypothermic response to ethanol in rats selectively bred for oral ethanol preference and nonpreference.  106:169-174. 1992
  • Nicotinic systems and cognitive function..  108:417-431. 1992
  • Suppression of alcohol and saccharin preference in rats by a novel Ca2+ channel inhibitor, Goe 5438..  107:447-452. 1992
  • Chronic alcohol consumption in alcohol-preferring P rats attenuates subsequent conditioned taste aversion produced by ethanol injections.  105:530-534. 1991
  • Importance of delta opioid receptors in maintaining high alcohol drinking.  103:467-472. 1991
  • d-Amphetamine-induced "floating limb" syndrome in young rhesus monkeys..  101:112-117. 1990
  • Chronic neuroleptic effects on spatial reversal learning in monkeys..  97:496-500. 1989
  • Radial-arm maze performance in rats is impaired by a combination of nicotinic-cholinergic and D2 dopaminergic antagonist drugs..  99:371-373. 1989
  • Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration..  94:421-427. 1988
  • Chronic neuroleptics alter the effects of the D1 agonist SK&F 38393 and the D2 agonist LY171555 on oral movements in rats..  96:253-257. 1988
  • Potential interactions between GABAb and cholinergic systems: baclofen augments scopolamine-induced performance deficits in the eight-arm radial maze..  96:116-120. 1988
  • Baclofen disrupts passive avoidance retention in rats..  92:398-401. 1987
  • Psychopharmacological investigations of a lead-induced long-term cognitive deficit in monkeys..  91:334-341. 1987
  • Tremorous mouth movements in rats administered chronic neuroleptics..  92:122-126. 1987
  • Memory performance by mild hypertensives following beta-adrenergic blockade..  89:20-24. 1986
  • Electroconvulsive treatment and haloperidol: effects on pre- and postsynaptic dopamine receptors in rat brain..  83:155-158. 1984
  • D-amphetamine in obsessive-compulsive disorder..  80:231-235. 1983
  • Modulating role of lithium on dopamine turnover, prolactin release, and behavioral supersensitivity following haloperidol and reserpine..  81:150-154. 1983
  • Acute treatment with trimethyltin alters alcohol self-selection..  78:19-22. 1982
  • An involvement of dopamine in higher order choice mechanisms in the monkey.  73:306. 1981
  • An involvement of dopamine in higher order choice mechanisms in the monkey..  72:173-177. 1981
  • Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats..  73:188-193. 1981
  • Perseverative behaviour after amphetamine; dissociation of response tendency from reward association..  75:283-286. 1981
  • "Go here-to there" performance after amphetamine: the importance of the response requirement in successive discrimination..  69:271-273. 1980
  • Attenuation of the effects of punishment by ethanol: comparisons with chlordiazepoxide..  71:123-129. 1980
  • Behavioral effects of dopamine agonists across the estrous cycle in rats..  71:147-151. 1980
  • Atypical antidopaminergic properties of CI-686: a potential antipsychotic agent..  66:23-27. 1979
  • Every-other-day acetylmethadol disturbs circadian cycles of human motility.  62:151-155. 1979
  • Inhibition of phenylethanolamine-N-methyltransferase and brain-stimulated reward..  57:39-42. 1978
  • Intracranial reward after Lilly 110140 (fluoxetine HCl): evidence for an inhibitory role for serotonin..  51:189-193. 1977
  • Varenicline effects on craving, cue reactivity and smoking reward.  218.